Slide 1: Excellent results across all businesses, guidance raised again
Excellent results across all businesses Guidance raised again Roland Busch, CEO Siemens AG Ralf P. Thomas, CFO Siemens AG Unrestricted | © Siemens 2021 | Investor Relations | Q2 Analyst Call | 2021-05-07
Slide 2: Notes and forward-looking statements
Notes and forward-looking statements This document contains statements related to our future business and financial performance and future events or developments involving Siemens that may constitute forward-looking statements. These statements may be identified by words such as “expect,” “look forw
Slide 3: Successful strategy execution and sustainable high performance
Successful strategy execution and sustainable high performance While recovery from pandemic gains traction… … stringent execution is key priority • Portfolio substantially strengthened Industrial production, Index: Dec 2019 = 100 120 • Competitiveness programs fully on track 110 +53% • Superior cust
Slide 4: Decisive steps to shape and strengthen our portfolio
Decisive steps to shape and strengthen our portfolio Acquisition of good progress • Closing as of April 15, 2021 • Both Next47 portfolio • US$ 16.4bn purchase price companies listed at NYSE • After equity raises Siemens • Continuing collaboration in stake at 75% partner ecosystem • Strong strategic
Slide 5: Digitalization offers tremendous opportunities – Siemens is setting the pace
Digitalization offers tremendous opportunities – Siemens is setting the pace Hanover Fair – Infinite opportunities from infinite data DI Software – Teamcenter is leader in PLM space • Unmatched virtual experience Digital Enterprise • > 22,000 visiting participants • > 70 auditorium presentations • >
Slide 6: Sustainability is core to our business – Technology with purpose
Sustainability is core to our business – Technology with purpose ESG – New commitments WEF Lighthouse factory Amberg Strategic partnership Leading edge Sustainable automotive Sustainability at the technologies for growth production through core of how we do while consuming less digitalization & ener
Slide 7: Siemens technologies deliver unique customer value
Siemens technologies deliver unique customer value DI - BioNTech SI - Charging solutions MO – New South Wales, Australia Accelerated production Infrastructure for zero- Higher capacity, more setup for Covid-19 emission public and reliability for Sydney vaccine individual transport train network Page
Slide 8: Q2 – Excellent results across all businesses
Q2 – Excellent results across all businesses Orders Revenue IB Adj. EBITA margin +11% +9% 15.1% EPS (all in) Free Cash Flow Indust. ND/EBITDA (all in) €2.82 €1.2bn 0.6x Note: Orders and Revenue growth comparable Page 8 Unrestricted | © Siemens 2021 | Investor Relations | Q2 Analyst Call | 2021-05-07
Slide 9: Digital Industries (DI): Excellent performance and market share gains
Digital Industries (DI) Excellent performance and market share gains Orders Revenue Orders: €bn Ongoing recovery in key end markets +8%1) +14%1) 4.2 4.3 Strength in short cycle automation 3.7 4.0 1.0 1.1 Revenue: 2.7 2.9 Broad based growth across all businesses China and U.S. sharply up Q2 FY 20 Q2
Slide 10: Digital Industries: China growth driver, Europe & US catching up
Digital Industries (DI) China continues to be growth driver, while Europe & US clearly catching up DI revenue exposure in vertical end markets Q2 FY 2021 - Key regions Automation (excl. Software) Market trend1) As of Q1/21 As of Q2/21 Orders +45% | Revenue +61% 20% Automotive Continued growth, PYQ e
Slide 11: Smart Infrastructure (SI): Continuing strength in product businesses
Smart Infrastructure (SI) Continuing strength in product businesses drives profitable growth Orders Revenue €bn Orders: +10%1) +6%1) Products and systems significantly up 3.8 4.0 Solutions and services return to moderate growth 3.5 3.6 1.3 1.4 2.2 2.2 Revenue: All regions up, China stands out Q2 FY
Slide 12: Mobility (MO): Solid performance, expect acceleration in H2
Mobility (MO) Solid performance, expect acceleration in H2 Orders Revenue Orders: €bn Lower volume of large orders 3%1) Pandemic related shift of projects into H2 FY 21 -8%1) 2.4 2.3 2.3 Massive acceleration in H2 expected 2.1 0.4 0.4 Revenue: 1.9 1.9 Clear growth in Rail Infrastructure Q2 FY 20 Q2
Slide 13: Below Industrial Businesses benefitting from portfolio gains
Below Industrial Businesses benefitting from portfolio gains Q2 FY 21 – Performance Below Industrial Businesses Expectations for FY 2021 excl. Varian €m Minorities • SFS: significant improvement over FY 2020, however, not at €125m pre-COVID-19 levels 874 2,390 • POC: positive contribution from fully
Slide 14: Free cash flow: Sharp improvement towards consistent cash conversion
Free cash flow Sharp improvement towards consistent cash conversion Free Cash Flow – Industrial Businesses €m +91% Excellent cash performance on higher profit and 3,612 improved operating working capital management 1,891 2,144 1,468 0.86 0.61 0.69 1.03 All businesses with cash conversion ahead of H1
Slide 15: Siemens Healthineers completed acquisition of Varian on April 15, 2021
Siemens Healthineers completed acquisition of Varian on April 15, 2021 • Accelerating Healthineers' impact on global healthcare Transformative • Establishing a strong player along the entire cancer care continuum Combination • Supporting Healthineers “Upgrading” strategy • As indicated, financed thr
Slide 16: Outlook FY 2021 raised again
Outlook FY 2021 raised again FY 2021 Siemens Group FY 2021 Framework Businesses • Book-to-bill >1 Comparable Adj. EBITA margin • Comparable revenue growth revenue growth expectation of 9 – 11% (previous mid to high-single digit) • Net income of €5.7 – €6.2bn Digital Industries 9 – 11% 20 – 21% (prev
Slide 17: Appendix
Appendix Page 17 Unrestricted | © Siemens 2021 | Investor Relations | Q2 Analyst Call | 2021-05-07
Slide 18: Siemens Financial Services (SFS)
Siemens Financial Services (SFS) Outstanding SFS profitability given still uncertain market environment Earnings before taxes (EBT) €m FY 2020: H1 FY 2021: Continuing recovery of SFS profitability RoE: 11.7% RoE: 17.0% Extraordinarily strong performance of Debt Business 212 36 156 Solid contribution
Slide 19: Net debt bridge Q2 FY 2021
Net debt bridge Q2 FY 2021 Ind. Net Debt/ EBITDA (c/o) in €bn Operating Activities 0.6x (Q1 FY21: 1.1x) therein: • ∆ Inventories -0.0 therein: 27.5 • ∆ Trade and other receivables -0.0 • Payout Dividends -2.8 26.4 4.9 • ∆ Trade payables +0.4 • FX revaluation from debt 21.6 • ∆ Contract Assets/Liabil
Slide 20: Provisions for pensions further improved in Q2
Provisions for pensions further improved in Q2, mainly due to increase of discount rate and extraordinary fundings Q FY 2020 – Pensions and similar obligations FY FY Q1 FY Q2 FY Q3 FY Q4 FY Q1 FY Q2 FY in €bn¹ 2018 2019 2020 2020 2020 2020 2021 2021 Defined benefit obligation (DBO)² -35.9 -40.3 -39.
Slide 21: Q2 FY 2021 Profit Bridge from SHS disclosure to SAG disclosure
Q2 FY 2021 Profit Bridge from SHS disclosure to SAG disclosure Different profit definitions at SHS and SAG to be considered in models in €m disclosure (as of May 3, 2021) disclosure (as of May 7, 2021) 17.8% 16.8% 17.1% 704 666 15.0% 679 25 -19 14 -25 42 -27 595 27 EBIT Transaction, Severance Amorti
Slide 22: H1 FY 2021 (YTD) Profit Bridge from SHS disclosure to SAG disclosure
H1 FY 2021 (YTD) Profit Bridge from SHS disclosure to SAG disclosure Different profit definitions at SHS and SAG to be considered in models in €m disclosure (as of May 3, 2021) disclosure (as of May 7, 2021) 17.9% 17.2% 17.7% 16.3% 1,404 1,386 -23 1,349 -37 1,278 -20 24 37 -66 66 EBIT Transaction, S
Slide 23: Siemens Healthineers outlook 2021 raised
Outlook as presented by Siemens Healthineers on May 3, 2021 Outlook 2021 raised due to stronger operational business, updated rapid antigen assumption and H2 Varian contribution Comparable revenue growth 1,3 Adj. basic EPS2,3 (€) Comp. 4 adj. Adj. EPS 14% to 17% EPS growth: ~16% to ~28% growth ex-FX
Slide 24: Post-closing transaction details
Varian transaction effects as reported by Siemens Healthineers on May 3rd Post-closing transaction details Post-closing transaction details ▪ Reporting as a new segment, fully transparent to capital markets Reporting & ▪ Harmonization of accounting methods, e.g. in revenue recognition Outlook ▪ H2 F
Slide 25: Financial calendar
Financial calendar May 10-12, 2021 June 10, 2021 June 25 - 30, 2021 Virtual Q2 JP Morgan Post CMD Roadshow Conference roadshow May 7, 2021 June 24, 2021 August 5, 2021 Q2 Earnings Capital Market Q3 Earnings Release Day Release Page 25 Unrestricted | © Siemens 2021 | Investor Relations | Q2 Analyst C
Slide 26: Investor Relations
Investor Relations Internet: www.siemens.com/investorrelations E-Mail: investorrelations@siemens.com Telephone: +49 89 636-32474 Fax: +49 89 636-1332474 Page 26 Unrestricted | © Siemens 2021 | Investor Relations | Q2 Analyst Call | 2021-05-07